Navigation Links
Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy
Date:12/19/2011

CARLSBAD, Calif., Dec. 19, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has initiated a Phase 1 study of ISIS-SMNRx in patients with spinal muscular atrophy (SMA).  SMA is a severe motor-neuron disease that is the leading genetic cause of infant mortality.  Isis is developing ISIS-SMNRx as a potential treatment for all Types of SMA.

"SMA is a devastating disease that leads to the loss of motor neurons resulting in muscle weakness and respiratory failure in children.  The genetic cause of this disease is well understood, but there are currently no effective disease-modifying therapies.  Currently, treatment of SMA is entirely symptomatic and focuses on preserving muscle strength and lung function by physical therapy and assisted ventilation.  This supportive approach has improved the natural history of SMA by extending life expectancy, but muscle weakness and atrophy are not affected.  A disease-modifying drug like ISIS-SMNRx that specifically targets the cause of the disease could, for the first time, restore muscle strength and respiratory function and dramatically improve the children's function and quality of life," said Darryl C. De Vivo, M.D., Sidney Carter Professor of Neurology and Pediatrics and Co-Director of the Motor Neuron Center at Columbia University Medical Center.

SMA is a severe genetic disease that affects approximately 30,000 – 35,000 patients in the United States, Europe and Japan.  One in 50 people, approximately 6 million people in the United States, are carriers of the SMA gene.  Carriers experience no symptoms and do not develop the disease, however, when both parents are carriers, there is a one in four chance that their child will have SMA.  SMA is caused by a loss of, or defect in, the survival motor neuron 1 (SMN1) gene leading to a decrease in
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Soligenix Initiates Next Generation Anthrax Vaccine Development Program Under Agreement With Harvard University
2. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers
3. Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer
4. Spring Creek Healthcare Systems Initiates Strategy to Partner and License DelRX Patents
5. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
6. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
7. Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
8. Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist
9. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
10. BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
11. Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
(Date:7/30/2015)... July 30, 2015   Gaumard® Scientific Company ... UNI®, the world,s first operating system to support ... available exclusively to Gaumard users. UNI® version 2.27.21.0 ... Newborn Tory™ S2200, as well as improvements to ... clinical measures such as EtCO 2 .  ...
(Date:7/30/2015)... , July 30, 2015 ... market ? Which areas are going to grow at ... shows you potential revenues to 2025, assessing data, trends, ... report provides 176 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
Breaking Medicine Technology:Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
(Date:7/30/2015)... ... ... On July 23rd Clay Today Online reported the state of Florida ... system, which has amassed largely enough throughout the years. Florida is the third state ... recent reduction of non violent drug offender’s prison sentences, Florida is beginning to take ...
(Date:7/30/2015)... ... July 30, 2015 , ... Quintessa Medical Spa is ... a nonsurgical treatment designed specifically for the elimination of excess tissue under ... first locations in the state of Wisconsin to offer this innovative treatment. , Developed ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Gummy smile ... lip lowering, gum contouring and surgery, as well as the patented gum depigmentation treatmet. ... has made him popular with many patients from around the world. , “Like treatment ...
(Date:7/30/2015)... Newark, NJ (PRWEB) , ... July 30, 2015 ... ... New Jersey's State-designated entity on behalf of the New Jersey Department of Health, ... for Health Information Technology, an agency of the U.S. Department of Health and ...
(Date:7/30/2015)... , ... July 30, 2015 , ... New research finds ... Click here to read more on the Surviving Mesothelioma website. , Researchers ... in Missouri reviewed more than 12,000 cases of mesothelioma occurring between 1990 and 2010. ...
Breaking Medicine News(10 mins):Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2
... 12 Stryker Corporation,(NYSE: SYK ) disclosed ... has made an informal inquiry of the Company ... in connection with the sale,of medical devices in ... U.S. Securities and Exchange Commission regarding this,informal investigation. ...
... Excerpta Medica, an Elsevier business that has delivered ... with corporate sibling Elsevier Interactive Solutions (EIS), an ... a decades experience creating online marketing and educational ... will now be able to offer customers in ...
... Foods Recall on Pot Pies containing Poultry and,Beef, ... recall by ConAgra Foods, announced it has removed from ... beef and poultry,because of possible Salmonella contamination. ConAgra announced ... carried by Giant Food and,subject to the recall are ...
... 12, 2007 For the first time, scientists have ... to a specific, chemical signature that may be ... laboratory tests. The signature reads chocolate lover in some ... the researchers say. , The study by Swiss ...
... (the,"Company", OTCBB: BIOHF) reports that in connection with a ... with the,Exchange policy and requirements, which resulted in the ... Directors of the Company has,decided that it is in ... the,Exchange to delist its shares on a voluntary basis ...
... , FRIDAY, Oct. 12 (HealthDay News) -- Multiple sclerosis that ... than the non-familial form, say University at Buffalo researchers. , ... MS patients and found that the 198 patients with familial ... of whole brain, white matter and gray matter, as well ...
Cached Medicine News:Health News:Study finds that people are programmed to love chocolate 2Health News:Familial MS May Be More Destructive 2
Inquire...
Inquire...
... Software is easy to configure for ... balance. Use the standard method or enter ... temperature, pressure, etc.) QualiTrace automatically manages the ... measurements from the balance to the software, ...
Reservoir, High Profile, Multi Well, 12 Row, Pyramid Bottom, 21mL Available Sterile...
Medicine Products: